Attached files
| file | filename |
|---|---|
| S-1 - FENNEC PHARMACEUTICALS INC. | v202208_s1.htm |
| EX-23.3 - FENNEC PHARMACEUTICALS INC. | v202208_ex23-3.htm |
|
EXHIBIT
23.2
|
|
 |
Ottawa
ON K1P 5T8
Canada
Tel:
613-236-2442
Fax.:
613-236-2195
www.deloitte.ca
|
CONSENT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We
consent to the use in this Registration Statement on Form S-1 of our report
dated March 30, 2010 relating to the consolidated financial statements of
Adherex Technologies Inc. (a development stage company) (the “Company”)
appearing in the Prospectus, which is part of this Registration
Statement.
We also
consent to the reference to us under the headings "Experts" in such
Prospectus.
/s/
Deloitte & Touche LLP
Independent
Registered Chartered Accountants
Licensed
Public Accountants
Ottawa,
Canada
November
12, 2010